NeuroNation
PrivateLast Round
Grant
Nov 5, 2021
Total Funding Raised
$7.19M
Company Overview
NeuroNation, a product of the German healthcare technology company Synaptikon GmbH, provides a scientifically-based online platform for cognitive training. It offers over 30 exercises developed in collaboration with scientific institutions like the Free University of Berlin to improve cognitive functions such as memory, attention, and processing speed. The platform serves individuals and businesses (B2C and B2B) with personalized training plans and progress tracking. A key offering is NeuroNation MED, a certified and prescribable medical application in Germany designed for patients with cognitive impairments. The company is venture-backed, having raised approximately $7.3 million in a Series A funding round in 2020.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Medical Devices, Subscription Commerce, Telemedicine
Business Model
B2C
Customer Profile
Subscription SaaS, Freemium, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroNation Comps
Public and private peers based on sector, stage, and business model.
NeuroNation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 5, 2021 | ||||
| Series A | Sep 7, 2021 | ||||
| Strategic | Jan 24, 2014 | ||||
| Seed | Nov 2, 2011 |
NeuroNation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Spiegel-Gruppe | Strategic |
| XLHealth AG | Strategic |
| Impact Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Digital health app now reimbursed by all statutory health insurance companies in Germany.
- Mar 1, 2026
Received the AOK-Leonardo digital prevention award.
NeuroNation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroNation's valuation, stock price, and market status.
